Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats

OBJECTIVE: To seek efficient aldose reductase inhibitors (ARIs) with excellent in vitro and in vivo biological activities against rat galactosemic cataract. METHODS: The method was firstly optimized to screen strong ARIs from nonoriented synthetic compounds and natural extracts. Then, diosgenin was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Lixia, Cheng, Lixia, Yang, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605930/
https://www.ncbi.nlm.nih.gov/pubmed/29038789
http://dx.doi.org/10.1155/2017/7309816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605930/
https://www.ncbi.nlm.nih.gov/pubmed/29038789
http://dx.doi.org/10.1155/2017/7309816

Ejemplares similares